Morning Read: Affymetrix mulls new bid, SCOTUS hears ACA contraception case
Plus, Paul Allen puts $100 million into high-risk biotech research, more California hospitals hit by ransomware and Roger Daltrey pushes 21st Century Cures legislation.
Morning Read: Affymetrix rejects the latest takeover bid meant to derail Thermo Fisher’s offer
Also, the latest hospital cyber attack (a ransomware attack), Zika gets political, a poll on the best kind of HIMSS keynotes, and the Valeant obituaries are rolling in.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Lucier makes first NuVasive acquisition: Buys Ellipse for $380M
Given Lucier's expertise in M&A, it'll be interesting to see how he expands NuVasive's product portfolio beyond this $380 million acquisition.
Thermo Fisher adds supply chain link with $175M Doe & Ingalls acquisition
Thermo Fisher Scientific (NYSE:TMO) is boosting its supply chain capabilities with its $175 million purchase of chemicals supplier Doe & Ingalls. Durham, North Carolina-based Doe & Ingalls provides specialty chemicals for companies in the life sciences and microelectronics industry. Doe & Ingalls’ 2011 revenue was approximately $110 million. The acquisition by Waltham, Massachusetts-based Thermo Fisher […]
Thermo Fisher to acquire Dionex
Thermo Fisher Scientific Inc. today announced a $2.1 billion acquisition of Sunnyvale, Calif.-based laboratory equipment maker Dionex Corp. Thermo Fisher Scientific Inc. (NYSE:TMO) today announced a deal to take over Sunnyvale Calif.-based Dionex Corp. (NSDQ:DNEX). The Waltham, Mass.-based lab instruments maker plans to pay about $2.1 billion in cash for Dionex, or $118.50 per share, […]
Thermo Fisher Scientific expanding in Australia
Thermo Fisher Scientific Inc. (NYSE:TMO) agreed to acquire Australian lab supplies provider Lomb Scientific for an undisclosed amount, in a bid to widen its footprint in Asia and the Middle East. Taren Point, New South Wales-based Lomb employs about 100 workers and posted sales of $34 million AUD last year (about $27 million in U.S. […]
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Healthcare CEOs earn the biggest bucks (Morning Read)
Healthcare company chief executives took home the biggest paychecks -- a median of $10 million -- of any industry covered by the recent Wall Street Journal CEO Compensation Study, according to the news organization's Health blog. CEOs from Thermo Fisher Scientific, Boston Scientific and Johnson & Johnson were among the top 20 in the list. Unitedhealth Group CEO Stephen Hemsley got the biggest raise last year.